ExodusPoint Capital Management’s Community Healthcare Trust CHCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-56,877
Closed -$946K 1582
2025
Q2
$946K Buy
56,877
+4,782
+9% +$78.9K 0.01% 979
2025
Q1
$946K Buy
52,095
+39,289
+307% +$749K 0.01% 935
2024
Q4
$246K Sell
12,806
-114,912
-90% -$2.08M ﹤0.01% 1327
2024
Q3
$2.32M Buy
127,718
+95,469
+296% +$1.95M 0.01% 672
2024
Q2
$754K Buy
+32,249
New +$784K 0.01% 1109
2024
Q1
Sell
-23,240
Closed -$619K 1534
2023
Q4
$619K Sell
23,240
-72,645
-76% -$2M ﹤0.01% 975
2023
Q3
$2.85M Buy
95,885
+22,596
+31% +$758K 0.03% 559
2023
Q2
$2.42M Buy
+73,289
New +$2.55M 0.02% 728
2021
Q2
Sell
-6,784
Closed -$313K 2391
2021
Q1
$313K Buy
+6,784
New +$315K ﹤0.01% 1638
2020
Q3
Sell
-8,696
Closed -$356K 1792
2020
Q2
$356K Buy
+8,696
New +$325K 0.01% 1232
2020
Q1
Sell
-10,300
Closed -$441K 1134
2019
Q4
$441K Buy
+10,300
New +$470K 0.01% 933

Other funds holding CHCT

ExodusPoint Capital Management's CHCT Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Community Healthcare Trust (CHCT) in Q3 2025, closing a stake of 56,877 shares — an estimated $946K sold.

ExodusPoint Capital Management first reported a position in CHCT in Q4 2019 and held it in 11 quarters. The position peaked at $2.85M in Q3 2023. 159 funds tracked by Wall St. Rank hold CHCT as of Q3 2025.

  • ExodusPoint Capital Management reported no remaining Community Healthcare Trust position as of Q3 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 56,877 Community Healthcare Trust shares in Q3 2025, an estimated $946K.
  • ExodusPoint Capital Management first reported a position in Community Healthcare Trust in Q4 2019 and held it in 11 quarters.
  • ExodusPoint Capital Management's Community Healthcare Trust position peaked at $2.85M in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Community Healthcare Trust as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.